dr sara m. tolaney: standard of care, novel approaches for treatment of her2-positive breast cancer
Published 6 years ago • 197 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
3:01
dr sara m. tolaney discusses the role of adjuvant therapy in her2-positive breast cancer
-
2:00
dr sara m. tolaney: challenges with treating, role of clinical trials in her2-positive breast cancer
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:20
dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
7:37
dr. tolaney highlights new breast cancer combination therapies
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
0:59
treatment for early stage her2 breast cancer | dana-farber cancer institute
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
1:35
dr. sanft on treatment options in her2-positive breast cancer
-
3:51
improving care for patients with metastatic breast cancer
-
59:39
er-positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
1:28
esmo22: breast cancer research by sara tolaney, md | dana-farber cancer institute
-
1:55
dr. tolaney on abemaciclib plus pembrolizumab for hr , her2- breast cancer
-
1:11
new breast cancer clinical trial: imlunestrant for breast cancer